Keymed Biosciences Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Keymed Biosciences Inc.
Two recent licensing deals involving Chinese firms underscore the record level of agreements being inked between innovative domestic biotechs and generic drug makers, at a time when corporate valuations and geopolitical tensions have made cross-border transactions harder to grab.
Accelerated initial public listings, multi-million dollar deals and hot investment fund influxes fuel an already record-setting July for biotech fundraising in China.
- Drug Discovery Tools
- Other Names / Subsidiaries
- Keymed Bioscience (Chengdu) Co., Ltd.
- Chengdu Keymed
- 2Health Biosciences Inc.